D.E. Shaw & Co
MDXG icon

D.E. Shaw & Co’s MiMedx Group MDXG Stock Holding History

D.E. Shaw & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Sell
312,696
-86,212
-22% -$434K ﹤0.01% 3280
2025
Q4 		$2.7M Sell
398,908
-305,316
-43% -$2.14M ﹤0.01% 2805
2025
Q3 		$4.92M Sell
704,224
-87,557
-11% -$609K ﹤0.01% 2221
2025
Q2 		$4.84M Buy
791,781
+185,209
+31% +$1.23M ﹤0.01% 2065
2025
Q1 		$4.61M Buy
606,572
+363,630
+150% +$3.04M ﹤0.01% 1957
2024
Q4 		$2.34M Buy
242,942
+113,191
+87% +$882K ﹤0.01% 2606
2024
Q3 		$767K Buy
129,751
+88,954
+218% +$589K ﹤0.01% 3450
2024
Q2 		$283K Sell
40,797
-89,639
-69% -$630K ﹤0.01% 3928
2024
Q1 		$1M Sell
130,436
-296,693
-69% -$2.38M ﹤0.01% 3096
2023
Q4 		$3.75M Sell
427,129
-236,584
-36% -$1.73M ﹤0.01% 2148
2023
Q3 		$4.84M Sell
663,713
-311,217
-32% -$2.32M 0.01% 1832
2023
Q2 		$6.44M Buy
974,930
+443,200
+83% +$2.26M 0.01% 1676
2023
Q1 		$1.81M Sell
531,730
-36,496
-6% -$141K ﹤0.01% 2758
2022
Q4 		$1.58M Buy
568,226
+101,289
+22% +$303K ﹤0.01% 3119
2022
Q3 		$1.34M Sell
466,937
-89,372
-16% -$318K ﹤0.01% 3354
2022
Q2 		$1.93M Sell
556,309
-12,555
-2% -$49.2K ﹤0.01% 3107
2022
Q1 		$2.68M Buy
568,864
+113,044
+25% +$553K ﹤0.01% 3015
2021
Q4 		$2.75M Buy
455,820
+266,901
+141% +$1.85M ﹤0.01% 3054
2021
Q3 		$1.15M Buy
188,919
+161,326
+585% +$1.82M ﹤0.01% 3499
2021
Q2 		$345K Buy
+27,593
New +$299K ﹤0.01% 4205
2018
Q4 		– Sell
-694,812
Closed -$4.29M – 3902
2018
Q3 		$4.29M Buy
694,812
+173,454
+33% +$784K 0.01% 1679
2018
Q2 		$3.33M Buy
+521,358
New +$3.71M ﹤0.01% 1827
2015
Q3 		– Sell
-171,076
Closed -$1.98M – 3822
2015
Q2 		$1.98M Sell
171,076
-389,318
-69% -$4.01M ﹤0.01% 2222
2015
Q1 		$5.83M Buy
560,394
+107,559
+24% +$1.01M 0.01% 1282
2014
Q4 		$5.22M Buy
452,835
+354,234
+359% +$3.5M 0.01% 1537
2014
Q3 		$703K Sell
98,601
-125,647
-56% -$876K ﹤0.01% 3093
2014
Q2 		$1.59M Buy
224,248
+165,181
+280% +$967K ﹤0.01% 2508
2014
Q1 		$362K Sell
59,067
-7,387
-11% -$54.3K ﹤0.01% 3820
2013
Q4 		$581K Buy
+66,454
New +$407K ﹤0.01% 3618

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

D.E. Shaw & Co's MDXG Position: Q1 2026 in Review

D.E. Shaw & Co reduced its MiMedx Group (MDXG) stake by 22% in Q1 2026, selling an estimated $434K and leaving 312,696 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3280.

D.E. Shaw & Co first reported a position in MDXG in Q4 2013 and has held it in 29 quarters since. The position peaked at $6.44M in Q2 2023. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • D.E. Shaw & Co held 312,696 shares of MiMedx Group worth $1.24M as of Q1 2026.
  • D.E. Shaw & Co sold 86,212 MiMedx Group shares in Q1 2026, an estimated $434K.
  • MiMedx Group made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3280 holding.
  • D.E. Shaw & Co first reported a position in MiMedx Group in Q4 2013 and has held it in 29 quarters since.
  • D.E. Shaw & Co's MiMedx Group position peaked at $6.44M in Q2 2023.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.